July 21, 2020 BORDEAUX, France & BOSTON–(BUSINESS WIRE)–Regulatory News: IMPLANET (Paris:ALIMP) (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in vertebral and knee-surgery implants, announces the marketing of its MADISON total knee replacement implants in the United States has begun. Ludovic Lastennet, CEO of IMPLANET, and Bede O’Connor, …